V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240016092 | 240008279 | 1.72 | 72 | Curative (C) | 2015-05-06 | 2015-05-19 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | N | 240034120 | LENALIDOMIDE |
| 240016093 | 240008281 | 1.77 | 68.5 | Palliative (P) | 2018-11-23 | 2019-01-14 | Trastuzumab Subcutaneous | 2 | N | 240034124 | CYTARABINE |
| 240016094 | 240008286 | 1.45 | 48.6 | Palliative (P) | 2019-02-03 | 2019-02-19 | Gemcitabine weekly | N | N | 240034144 | BORTEZOMIB |
| 240016095 | 240008289 | 1.58 | 58 | Curative (C) | 2014-07-11 | 2015-07-09 | Cisplatin + Etoposide po&iv 3 day | 2 | Y | 240034148 | IBRUTINIB |
| 240016096 | 240008298 | 1.76 | 66.3 | Curative (C) | 2015-07-20 | 2015-07-21 | GDP | N | N | 240034166 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 240016097 | 240012456 | 1.75 | 80.5 | Curative (C) | 2016-06-01 | 2016-06-13 | Chlorambucil | null | null | 240034321 | CHLORAMBUCIL |
| 240016098 | 240008326 | 1.8 | 73 | Disease modification (D) | 2013-09-25 | 2013-10-08 | Hydroxycarbamide | 2 | null | 240034332 | CISPLATIN + TOPOTECAN |
| 240016099 | 240008329 | 0 | 82.5 | Disease modification (D) | 2017-05-10 | 2017-05-10 | CHLORAMBUCIL + RITUXIMAB | N | N | 240034344 | CHLORAMBUCIL + RITUXIMAB |
| 240016100 | 240008344 | 1.7 | 68.9 | Palliative (P) | 2014-08-28 | 2014-08-30 | Cyclophosphamide High Dose | N | N | 240034422 | FCR |
| 240016101 | 240014399 | 1.58 | 72 | Curative (C) | 2019-03-26 | 2019-04-08 | R Chlorambucil | N | N | 240034478 | CHLORAMBUCIL + RITUXIMAB |
| 240016102 | 240015877 | null | 55.2 | null | 2018-05-19 | 2018-09-24 | R Chlorambucil | 01 | N | 240034537 | CHLORAMBUCIL + RITUXIMAB |
| 240016103 | 240012476 | 1.65 | null | Palliative (P) | 2016-07-21 | 2016-07-27 | BEAM | 02 | null | 240034540 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240016104 | 240012480 | null | 61 | null | null | 2019-01-30 | METHOTREXATE | N | N | 240034558 | GEMCITABINE |
| 240016105 | 240008384 | null | 68.3 | Palliative (P) | 2014-06-24 | 2014-06-24 | DHAP | N | N | 240034689 | CARBOPLATIN + ETOPOSIDE |
| 240016106 | 240014410 | 1.81 | 67 | Disease modification (D) | 2016-08-26 | 2016-08-27 | Methotrexate High Dose (3g/m2) | N | N | 240034744 | CYTARABINE |
| 240016107 | 240008400 | null | 59 | Palliative (P) | 2016-09-17 | 2017-04-07 | R Chlorambucil | 02 | N | 240034778 | CHLORAMBUCIL + RITUXIMAB |
| 240016108 | 240008405 | 1.63 | 81 | Palliative (P) | 2017-11-16 | 2017-11-26 | Brentuximab Vedotin | 2 | N | 240034784 | BRENTUXIMAB |
| 240016109 | 240008445 | 1.69 | 86.2 | Palliative (P) | 2009-01-24 | 2014-06-08 | Bendamustine +/- Prednisolone | N | null | 240035100 | HYDROXYCARBAMIDE |
| 240016110 | 240008450 | 0 | 70 | Palliative (P) | 2016-06-29 | 2016-06-29 | METHOTREXATE | 02 | N | 240035134 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240016111 | 240008450 | 1.68 | 74.5 | Adjuvant (A) | 2015-03-17 | 2015-11-01 | BENDAMUSTINE | N | N | 240035134 | BEAM |
| 240016112 | 240008466 | 1.7 | 74 | Palliative (P) | 2012-07-01 | 2013-08-17 | Carboplatin + Etoposide IV 3 day | N | N | 240035318 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 240016113 | 240008472 | null | 122 | Disease modification (D) | 2018-02-02 | 2018-02-09 | Hydroxycarbamide | N | N | 240035319 | LEAM |
| 240016114 | 240008482 | 1.68 | 81.1 | Palliative (P) | 2020-01-14 | 2020-01-14 | GEMCITABINE | N | N | 240035348 | DHAP |
| 240016115 | 240008484 | null | 78.9 | Palliative (P) | 2015-05-20 | 2015-06-16 | Cyclophosphamide + Dex + Rituximab | Y | N | 240035356 | GDP |
| 240016116 | 240008490 | 1.63 | 59.6 | Curative (C) | 2015-07-18 | 2015-07-18 | Cytarabine Low Dose | N | N | 240035436 | DHAP |
| 240016117 | 240008497 | 0 | 48 | Palliative (P) | 2018-11-16 | 2018-11-28 | LEAM | N | N | 240035459 | IBRUTINIB |
| 240016118 | 240016144 | 1.61 | null | null | 2014-10-28 | 2014-10-30 | Methotrexate High Dose (3g/m2) | N | N | 240035460 | CARBOPLATIN + ETOPOSIDE |
| 240016119 | 240008512 | 1.77 | null | Curative (C) | 2017-07-22 | 2017-07-30 | IBRUTINIB | N | N | 240035551 | BENDAMUSTINE |
| 240016120 | 240008521 | 1.57 | null | Curative (C) | 2014-02-22 | 2015-07-16 | Carboplatin + Etoposide iv&po | null | N | 240035582 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 240016121 | 240008530 | 1.7 | 66.5 | Disease modification (D) | 2016-03-06 | 2016-03-06 | CAV | N | N | 240000290 | TRIPLE INTRATHECAL |
| 240016122 | 240008539 | null | 80 | Disease modification (D) | 2019-03-09 | 2019-04-05 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | 2 | N | 240000791 | CETUXIMAB |
| 240016123 | 240008556 | 1.66 | null | null | 2017-05-27 | 2017-05-29 | AML16 DA 3+10 | N | N | 240001549 | BEACOPP |
| 240016124 | 240008565 | 1.59 | 70.2 | Palliative (P) | 2016-01-27 | 2016-08-18 | DA-EPOCH-R | N | N | 240002318 | RUXOLITINIB |
| 240016125 | 240008571 | 1.69 | 75.9 | Palliative (P) | null | 2017-03-25 | EC | N | null | 240002486 | TOPOTECAN |
| 240016126 | 240012587 | 1.72 | null | Palliative (P) | 2017-05-03 | 2017-05-17 | Triple / Double Intrathecal Therapy | N | N | 240003250 | RUXOLITINIB |
| 240016127 | 240008601 | 1.66 | 79.3 | Palliative (P) | null | 2014-04-17 | Cytarabine HD + Methotrexate HD | N | N | 240005033 | ALEMTUZUMAB |
| 240016128 | 240008605 | 1.8 | 91.4 | Curative (C) | 2015-04-10 | 2015-04-14 | FLAG | 2 | N | 240005082 | OFATUMUMAB |
| 240016129 | 240008637 | 1.68 | 76 | Palliative (P) | 2017-09-24 | 2017-09-24 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | null | 240007399 | CARBOPLATIN + TOPOTECAN |
| 240016130 | 240008641 | 1.69 | 48.4 | Curative (C) | 2016-08-08 | 2016-08-08 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | 02 | N | 240007767 | CISPLATIN + PACLITAXEL |
| 240016131 | 240015909 | 1.66 | 57.8 | Curative (C) | 2016-12-24 | 2017-01-03 | MERCAPTOPURINE + METHOTREXATE + VINCRISTINE | N | N | 240007918 | R CODOX M |
| 240016132 | 240008651 | 1.59 | null | Curative (C) | 2017-03-08 | 2017-03-07 | Vinblastine | 2 | N | 240008306 | mEOC TRIAL |
| 240016133 | 240012628 | 1.74 | null | Palliative (P) | 2014-10-06 | 2014-10-06 | PMitCEBO-R | 02 | N | 240008851 | IVAC |
| 240016134 | 240008672 | 1.61 | 49.7 | Curative (C) | 2016-09-07 | 2016-10-27 | CISPLATIN + FLUOROURACIL + RT | N | N | 240009295 | GALLIUM TRIAL |
| 240016135 | 240012631 | 1.86 | 64.4 | Palliative (P) | 2018-02-19 | 2018-02-19 | BENDAMUSTINE + OFATUMUMAB | N | null | 240009614 | CARMUSTINE + THIOTEPA |
| 240016136 | 240008681 | 1.52 | null | Disease modification (D) | 2017-05-05 | 2017-05-06 | DA-EPOCH-R | 02 | N | 240009661 | ETOPOSIDE |
| 240016137 | 240014495 | 1.65 | null | Palliative (P) | 2016-07-18 | 2016-07-20 | CYTARABINE + METHOTREXATE | 2 | N | 240009723 | ICE-R |
| 240016138 | 240008696 | 1.63 | 44.5 | Palliative (P) | 2019-11-27 | 2020-03-11 | CAV | N | N | 240010391 | CISPLATIN + FLUOROURACIL |
| 240016139 | 240008703 | 1.65 | 71 | Palliative (P) | 2019-04-11 | 2019-04-15 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 240010545 | IVAC |
| 240016140 | 240008713 | 1.68 | 91.4 | Curative (C) | 2018-12-04 | 2018-12-04 | CODOX M | N | N | 240011523 | PILOT TRIAL |
| 240016141 | 240008716 | 1.71 | 61 | Curative (C) | 2018-10-02 | 2018-10-02 | Cytarabine High Dose | 02 | null | 240011575 | CISPLATIN + GEMCITABINE |